GS-6624 Uses, Dosage, Side Effects and more

GS-6624 has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.

Trade Name GS-6624
Generic Simtuzumab
Simtuzumab Other Names GS-6624, Simtuzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share